ESC 365 - Fibroblast growth factor 23 is a strong independent marker of poor outcome after an acute coronary syndrome

ESC Professional Premium Access

Fibroblast growth factor 23 is a strong independent marker of poor outcome after an acute coronary syndrome

Session: Preclinical and clinical laboratory markers in chronic coronary syndromes

Topic: Prevention

Speaker: Doctor A. Kallmeyer (Madrid, ES)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Andrea Kallmeyer

Fundacion Jimenez Diaz University Hospital, Madrid (Spain)

0 follower

6 more presentations in this session

CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-lymphocyte ratio (NLR) induced by acute myocardial infarction

Speaker: Professor B. Kingwell (Melbourne, AU)

Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

Speaker: Mr D. Fueller (Atlanta, US)

Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study

Speaker: Doctor S. Fathieh (Sydney, AU)

Formation of denser plasma fibrin clots is associated with coronary artery ectasias and aneurysms - preliminary results from the CARE-ANEURYSM study

Speaker: Doctor J. Chmiel (Krakow, PL)

Serum levels of the endoplasmic-reticulum-stress chaperone GRP78 are associated with inflammation, identify patients with coronary artery disease and predict mortality

Speaker: Doctor M. Al Zaidi (Bonn, DE)

Access the full session

Preclinical and clinical laboratory markers in chronic coronary syndromes

Speakers: Doctor A. Kallmeyer, Professor B. Kingwell, Mr D. Fueller, Doctor S. Fathieh, Doctor J. Chmiel...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources